POLYMED.BOPOLYMED.BOBSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR-14.9%
5Y CAGR+8.3%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-14.9%/yr
vs +39.7%/yr prior
5Y CAGR
+8.3%/yr
Recent deceleration
Acceleration
-54.6pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202526.38%
20249.21%
2023-5.16%
202242.81%
202110.07%
202017.67%
20191.01%
201811.22%
20173.70%
20162.89%